SCHEMBL17437568

SCHEMBL17437568

Cn1c(-n2ncnc2N)nc2cncc(-c3ccc(Cl)cc3Cl)c21

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 3/20 0.37
▸ DPP8 Q6V1X1 2/20 0.37
▸ HSD11B1 P28845 5/20 0.36
▸ LMNA P02545 1/20 0.35
▸ EGLN2 Q96KS0 1/20 0.33
▸ HSP90AA1 P07900 2/20 0.33
▸ HSP90AB1 P08238 2/20 0.33
▸ F2RL3 Q96RI0 1/20 0.32
▸ TNKS O95271 1/20 0.32
▸ CLK1 P49759 1/20 0.31
▸ PDE2A O00408 1/20 0.31
▸ CNR1 P21554 1/20 0.31
▸ KCNH2 Q12809 1/20 0.31
▸ CHRNB1 P11230 1/20 0.31
▸ CHRNB2 P17787 1/20 0.31
▸ CHRNB4 P30926 1/20 0.31
▸ CHRNA3 P32297 1/20 0.31
▸ CHRNB3 Q05901 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17437549 0.87 DPP4 (0.36) DPP4DPP8LMNAF2RL3
SCHEMBL17437310 0.87 CYP1A2 (0.40) DPP4DPP8HSD11B1LMNAEGLN2
SCHEMBL17437523 0.87 DPP4 (0.39) DPP4DPP8LMNAEGLN2HSP90AA1
SCHEMBL17437394 0.84 CYP1A2 (0.33) DPP4DPP8LMNAEGLN2CNR1
SCHEMBL17437382 0.84 USP2 (0.36) DPP4LMNAEGLN2HSP90AB1
SCHEMBL17437381 0.81 CRHR1 (0.35) LMNACNR1CHRNB1CHRNB2CHRNB4
SCHEMBL17437512 0.79 CYP11B2 (0.34) EGLN2
SCHEMBL17437387 0.79 CYP1A2 (0.37) DPP4DPP8HSP90AA1
SCHEMBL17437559 0.78 SIK1 (0.33) DPP4DPP8
SCHEMBL17437388 0.78 EGLN2 (0.34) DPP4DPP8EGLN2CLK1PDE2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170050963-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2017-02-23 — — US disclosed
US-9512120-B2 Microbicidally active imidazopyridine derivatives SYNGENTA PARTICIPATIONS AG (CH) 2016-12-06 — — US disclosed
US-20160016949-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2016-01-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170050963-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES IDO1, IDO2, FOXM1 DPP4 413/4885DPP8 1985/4885HSD11B1 3026/4885
US-20160016949-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES IDO1, IDO2, FOXM1 DPP4 413/4885DPP8 1985/4885HSD11B1 3026/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback